Results
|
18661.
|
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study. [electronic resource] by
- Ott, Patrick A
- Bang, Yung-Jue
- Berton-Rigaud, Dominique
- Elez, Elena
- Pishvaian, Michael J
- Rugo, Hope S
- Puzanov, Igor
- Mehnert, Janice M
- Aung, Kyaw L
- Lopez, Juanita
- Carrigan, Marion
- Saraf, Sanatan
- Chen, Mei
- Soria, Jean-Charles
Producer: 20170908
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35
Availability: No items available.
|
|
18662.
|
|
|
18663.
|
|
|
18664.
|
Tamoxifen-Dependent Induction of AGR2 Is Associated with Increased Aggressiveness of Endometrial Cancer Cells. [electronic resource] by
- Hrstka, Roman
- Podhorec, Jan
- Nenutil, Rudolf
- Sommerova, Lucia
- Obacz, Joanna
- Durech, Michal
- Faktor, Jakub
- Bouchal, Pavel
- Skoupilova, Hana
- Vojtesek, Borivoj
Producer: 20170821
In:
Cancer investigation vol. 35
Availability: No items available.
|
|
18665.
|
Promoter-level transcriptome in primary lesions of endometrial cancer identified biomarkers associated with lymph node metastasis. [electronic resource] by
- Yoshida, Emiko
- Terao, Yasuhisa
- Hayashi, Noriko
- Mogushi, Kaoru
- Arakawa, Atsushi
- Tanaka, Yuji
- Ito, Yosuke
- Ohmiya, Hiroko
- Hayashizaki, Yoshihide
- Takeda, Satoru
- Itoh, Masayoshi
- Kawaji, Hideya
Producer: 20190716
In:
Scientific reports vol. 7
Availability: No items available.
|
|
18666.
|
|
|
18667.
|
|
|
18668.
|
Sentinel Lymph Node Biopsy in the Treatment of Endometrial Cancer: Why We Fail? Results of a Prospective Multicenter Study on the Factors Associated with Failure of Node Mapping with Indocyanine Green. [electronic resource] by
- Ianieri, Manuel Maria
- Puppo, Andrea
- Novelli, Antonia
- Campolo, Federica
- Staniscia, Tommaso
- Di Martino, Giuseppe
- Piovano, Elisa
- Bruni, Francesco
- Roviglione, Giovanni
- Mautone, Daniele
- Ceccaroni, Marcello
Producer: 20191023
In:
Gynecologic and obstetric investigation vol. 84
Availability: No items available.
|
|
18669.
|
|
|
18670.
|
|
|
18671.
|
|
|
18672.
|
Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. [electronic resource] by
- Brown, Tommy A
- Byrd, Kevin
- Vreeland, Timothy J
- Clifton, Guy T
- Jackson, Doreen O
- Hale, Diane F
- Herbert, Garth S
- Myers, John W
- Greene, Julia M
- Berry, John S
- Martin, Jonathan
- Elkas, John C
- Conrads, Thomas P
- Darcy, Kathleen M
- Hamilton, Chad A
- Maxwel, George L
- Peoples, George E
Producer: 20200814
In:
Cancer medicine vol. 8
Availability: No items available.
|
|
18673.
|
|
|
18674.
|
|
|
18675.
|
|
|
18676.
|
|
|
18677.
|
|
|
18678.
|
|
|
18679.
|
|
|
18680.
|
|